Whole Genome and Exome Sequencing Markets Report 2023-2027: Industry on Verge of Breakout in Healthcare, Consumer and Agricultural Markets

Research and Markets
·6 min read
Company Logo
Company Logo

Dublin, Feb. 08, 2023 (GLOBE NEWSWIRE) -- The "Whole Genome and Exome Sequencing Markets by Application, Organism and Product with Executive and Consultant Guides. Includes Direct to Consumer Analysis 2023 to 2027" report has been added to ResearchAndMarkets.com's offering.

The report forecasts the market size out to 2023. The report includes detailed breakouts for 14 countries and 5 regions.

Will all newborns receive Whole Genome Sequencing at birth? How fast will Direct to Consumer Testing grow? What sequencing technology will take the lead? What's holding the industry back? Where are the over 800 locations that have high throughput devices?

The plummeting costs for Whole Genome Sequencing are creating a gold rush for market players. New consumers, new technologies, new specializations. In a situation reminiscent of the birth of the internet industry a wide range of well funded players are racing for market share on a truly global stage.

Tumor Cell Sequencing? Direct to Consumer? Gene Expression? Find out about the technology in readily understood terms that explain the jargon. What are the issues? Find the opportunities and the pitfalls. Understand growth expectations and the ultimate market forecasts for the next five years.

All report data is available in Excel format on request. Make investment decisions and valuations with confidence using the latest data.

Key Topics Covered:

Market Overview

Market Participants Play Different Roles

  • Instrument Manufacturer

  • Independent lab specialized/esoteric

  • Independent lab national/regional

  • Independent lab analytical

  • Public National/regional lab

  • Hospital lab

  • Physician lab

  • DTC Lab

  • Sequencing Labs

  • Audit body

Whole Genome Sequencing - Markets, Examples and Discussion

  • Direct to Consumer - Two Approaches

  • The New Age of Medical Information

  • Dangers in DTC-WGS - Health Costs and Regulation

  • Newborn and Prenatal - A Brave New World

  • DTC - How Many Segments?

  • Research Markets

  • Research Funding and Capital Expense

  • WGS Datasets Preferred

  • Existing research repurposed

  • Organism Wide Market

  • Service Suppliers Respond

  • Clinical - Understanding Germline and Somatic

  • Somatic - Chasing Mutations and Pharmacogenomics

  • Pathogen Testing

  • The Hepatitis C Story

  • Will the Microbiology Department Disappear?

  • AgriBio - Big Business

  • GMO is Here to Stay

  • WGS Benefits and Risks

  • The New Agriculture

Industry Structure

  • Hospital's Testing Share

  • Economies of Scale

  • Instrument Manufacturer Role

  • Healthcare Industry Impacts - Still Struggling

  • Can the Healthcare Industry Adapt?

  • Genetic Counselling as an Industry

  • WGES Adoption and Cannibalization

  • The Meaning of Grail

Market Trends

Factors Driving Growth

  • Diagnostic Factors

  • Interpreting the Code Otherwise

  • Changes in Agriculture

  • Fertility Technology Comes of Age

  • Pathogen Challenges

Factors Limiting Growth

  • Increased Competition Lowers Price

  • Lower Costs

  • Healthcare Cost Concerns Curtail Growth

  • Wellness has a downside

  • GMO Opposition Movement

Sequencing Instrumentation

  • Instrumentation Tenacity

  • Declining Cost Changes Industry Structure

  • LISTING of CURRENT NGS INSTRUMENT SPECIFICATIONS

  • llumina

  • ION

  • Pacific Biosystems

  • Roche

  • SOLiD

  • Oxford Nanopore

  • What is Oxford Nanopore Sequencing?

  • What can Oxford Nanopore Sequencing be used for?

  • Oxford Nanopore Products

  • Long Reads - Further Segmentation

  • Linked Reads

  • Targeted Sequencing Adopts CRISPR

  • New Sequencing Technologies

  • RNAP sequencing

  • In vitro virus high-throughput sequencing

  • Tunnelling currents DNA sequencing

  • Sequencing by hybridization

  • Sequencing with mass spectrometry

  • Microfluidic Sanger sequencing

  • Microscopy-based techniques

WGES Recent Developments

  • Genomics England, Aims to Sequence 100K Newborns

  • Juno Diagnostics NIPT With At-Home Sample Collection

  • Cardio Diagnostics Launches Genetic Cardio Risk Test

  • Universal Genetic Testing in Breast Cancer Further Supported

  • Aniling Gets CE-IVD Marks for Cancer Sequencing Tests

  • MyOme Lands Investment for WGS

  • GenomSys Gains CE Mark for New Genomic Analysis Software

  • WGS Finds Lung Cancers Fall Into Molecular Subtypes

  • Testing Distinguishes Benign Tumors From Precancerous Condition

  • Plan to Sequence All Newborns in UK

  • Clear Labs Raises $60M for Nanopore Sequencing

  • Variantyx Expands Into Prenatal, Cancer Testing

  • Whole-Genome Sequencing Aids Diagnosis in Stockholm

  • Variantyx Raises $20M

  • Nonacus WGS Service for SARS-CoV-2 Laboratories

  • Center to Report Risk Scores in Clinical WGS

  • Stanford Launches WGS for Cardiovascular Testing

  • Illumina and NY Healthcare Partner on Clinical WGS

  • Increased Adoption of WGS Needs Acceptance by Payors, Providers

  • Veritas Intercontinental Completes €5M Series B Financing Round

  • M2GEN and Discovery Life Sciences in Bioinformatics Agreement

  • Genomics England Adopts Quantum ActiveScale Object Storage

  • GenomiQa, Icon Group to Validate Genomic Analysis Platform CapeDx

  • NHS Wales Introduces WGS for Critically Ill Newborns

  • Illumina Achieves EAU for NGS-Based SARS-CoV-2 Test

  • C2i Genomics to Launch Trials for MRD Detection Tech

  • Roche Acquires Sequencing Company Stratos Genomics

  • UK COVID-19 Sequencing Consortium Launches

  • Invitae Acquires Three Companies: YouScript, Genelex, Diploid

  • Experience From Centralized Genomic Medicine Lab

  • MGI to Enable $100 Human Genome

  • Nebula Genomics offers $299 WGS

  • Team to Study Campylobacter Omics

  • Veritas Genetics Restarts US Business

  • NEOGEN, Gencove partner to advance animal genomics

  • UK Whole-Genome Sequencing Project Obtains £200M

  • WGS may help with disease outbreaks

  • Veritas Cuts WGS Price by 40%

  • Dante Labs Launches GenomeL, Long Reads Human Whole Genome Sequencing

  • Machine-learning system used to diagnose genetic diseases

  • Whole Genome Sequencing for healthy creates controversy

  • Nebula Genomics Offers FREE Whole Genome Sequencing

Profiles of Key Companies

  • 10x Genomics, Inc

  • Diagnostics

  • 23andME Inc

  • Abbott Laboratories

  • AccuraGen Inc

  • Adaptive Biotechnologies

  • Admera Health, LLC

  • Agilent/Dako

  • Akonni Biosystems

  • Amoy Diagnostics Co., Ltd

  • Ancestry.com LLC

  • Anchor Dx

  • ARUP Laboratories

  • Baylor Miraca Genetics Laboratories

  • Beckman Coulter Diagnostics

  • Becton, Dickinson and Company

  • BGI Genomics Co. Ltd

  • Bioarray Genetics

  • Biocept, Inc.

  • Biodesix Inc.

  • BioFluidica

  • BioGenex

  • Biolidics Ltd

  • bioMerieux Diagnostics

  • Bioneer Corporation

  • Bio-Rad Laboratories, Inc

  • Bio-Techne

  • C2i Genomics

  • Caris Molecular Diagnostics

  • CellMax Life

  • Centogene

  • Circulogene

  • Clear Labs

  • Clinical Genomics

  • Complete Genomics, Inc. - A BGI Company

  • Dante Labs

  • Datar Cancer Genetics Limited

  • Day Zero Diagnostics.

  • Diasorin S.p.A

  • Epic Sciences

  • Epigenomics AG

  • Eurofins Scientific

  • Excellerate Bioscience

  • Fabric Genomics

  • Freenome

  • FUJIFILM Wako Diagnostics

  • Fujirebio

  • Fulgent Genetics

  • GE Global Research

  • Gencove

  • Genedrive

  • GeneFirst Ltd

  • Genetron Holdings

  • Genewiz

  • Genomics England

  • Genomics Personalized Health (GPH)

  • GenomOncology

  • Genzyme Corporation

  • Grifols

  • Guardant Health

  • Guardiome

  • HeiScreen

  • Helix

  • Helomics

  • Hologic

  • HTG Molecular Diagnostics

  • Human Longevity, Inc

  • iCellate

  • Illumina

  • Incell Dx

  • Inivata

  • Invitae Corporation

  • Invivoscribe

  • Karius

  • Lunglife AI Inc

  • Macrogen

  • MDNA Life SCIENCES, Inc

  • MDx Health

  • Medgenome

  • Meridian Bioscience

  • Mesa Biotech (Thermo Fisher)

  • Mesa Laboratories, Inc

  • miR Scientific

  • MNG Labs

  • NantHealth, Inc

  • Natera

  • Nebula Genomics

  • NeoGenomics

  • New England Biolabs, Inc

  • Novogene Bioinformatics Technology Co., Ltd

  • Omega Bioservices

  • Oncocyte

  • OncoDNA

  • OpGen

  • ORIG3N, Inc

  • Origene Technologies

  • Oxford Nanopore Technologies

  • Panagene

  • Pathogenomix

  • Perkin Elmer

  • Personal Genome Diagnostics

  • Personalis

  • Precipio

  • PrecisionMed

  • Promega

  • Protagen Diagnostics

  • Qiagen

  • QuantuMDx

  • Regeneron Pharmaceuticals

  • Roche Molecular Diagnostics

  • Roswell Biotechnologies

  • Seegene

  • Sequencing.com

  • Siemens Healthineers

  • simfo GmbH

  • Singlera Genomics Inc

  • SkylineDx

  • Standard BioTools

  • Sure Genomics, Inc

  • Sysmex

  • Sysmex Inostics

  • Tempus Labs, Inc

  • Thermo Fisher Scientific Inc

  • Variantyx

  • Volition

  • Vyant Bio


For more information about this report visit https://www.researchandmarkets.com/r/sonr8d-genome-and?w=12

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood,Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900